Zenotech Laboratories (BOM:532039) Margin of Safety % (DCF FCF Based): N/A (As of Jul. 04, 2026)


BOM:532039 Zenotech Laboratories Ltd BOM:532039
73 GF Score
Price ₹45.91
GF Value ₹65.19
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Zenotech Laboratories Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Zenotech Laboratories's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

BOM:532039 vs ZTS, UTHR: Margin of Safety % (DCF FCF Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Zenotech Laboratories's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zenotech Laboratories Margin of Safety % (DCF FCF Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zenotech Laboratories's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Zenotech Laboratories's Margin of Safety % (DCF FCF Based) falls into.


BOM:532039
73GF Score
Zenotech Laboratories Ltd BOM:532039
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Zenotech Laboratories (BOM:532039) Overvalued in 2026?

Based on GuruFocus' analysis, Zenotech Laboratories stock appears to be undervalued. The current stock price of ₹45.91 is trading 29.6% below its estimated GF Value™ of ₹65.19. GuruFocus considers Zenotech Laboratories to be Significantly Undervalued.

Key valuation signals for BOM:532039:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: ₹65.19 vs. price of ₹45.91 (29.6% below fair value)
  • GF Score™: 73/100 with 1 warning sign

No single metric tells the full story. See the BOM:532039 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zenotech Laboratories Business Description

Address Survey No. 250-252, Turkapally Village, Shamirpet Mandal, RR District, Hyderabad, TG, IND, 500 078
Zenotech Laboratories Ltd is an India-based pharmaceutical company. It is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing biotechnology products. The Company's injectables product portfolio serves niche therapy areas like oncology and anesthesiology. It also manufactures products such as granulocyte-colony stimulating factor (GCSF) and Granulocyte-macrophage colony-stimulating factor (GMCSF). The company earns a vast majority of the revenue from the sale of its contract research and manufacturing services.
73GF Score

Get the complete analysis for BOM:532039

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹45.91
Price
₹65.19
GF Value